ZBIO Q2 2025 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena

ZBIOZenas BioPharma, Inc.

$1B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$43M

Operating Income

-$55M

Net Income

-$52M

EPS (Diluted)

$-1.25

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$42M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$293M

Total Liabilities

$53M

Stockholders' Equity

$240M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$43M	-$34M	-27.3%
Operating Income	-$55M	-$40M	-38.9%
Net Income	-$52M	-$38M	-37.5%